Abstract
Ten xenograft lines of human colonic and rectal carcinomas have been established in immune-suppressed mice. Mice bearing tumours in the 2nd to 6th passage were treated with maximum tolerated doses of 8 chemotherapeutic agents and tumour growth delay was estimated in terms of the number of volume doubling times gained by the treatment. The average response corresponded to a delay of only about 0.5 doubling times, but some tumour lines showed a good response to some agents. Twenty-three out of about 700 treated tumours failed to regrow. Statistical analysis showed no consistent difference in sensitivity among the tumour lines, but melphalan, 5-fluorouracil and hexamethylmelamine stood out as the most effective agents. A study of two-drug combinations showed that their order of administration had little effect on response. Only 4 of the patients who donated the xenografts were treated with chemotherapy, but among these there was some evidence that response in the xenografts correlated with response in the patient.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Nowak, K., Peckham, M. & Steel, G. Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer 37, 576–584 (1978). https://doi.org/10.1038/bjc.1978.87
Issue Date:
DOI: https://doi.org/10.1038/bjc.1978.87
This article is cited by
-
Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract
Cancer Chemotherapy and Pharmacology (1989)
-
Human tumor xenografts as model for drug testing
CANCER AND METASTASIS REVIEW (1988)
-
Tumor inhibition by titanocene complexes: Influence upon two xenografted human lung carcinomas
Journal of Cancer Research and Clinical Oncology (1987)
-
Development of new anti-cancer drugs
Medical Oncology and Tumor Pharmacotherapy (1986)